Comparison of tafenoquine (WR238605) and primaquine in the post-exposure (terminal) prophylaxis of vivax malaria) in Australian Defence Force personnel


Autoria(s): Nasveld, P.; Kitchener, S.; Edstein, M.; Rieckmann, K.
Contribuinte(s)

C.A. Brown

Data(s)

01/01/2002

Resumo

On return from duty in North Solomons Province (including Bougainville Island), Papua New Guinea, 586 Australian Defence Force personnel received either primaquine (14-d) or tafenoquine (3-d) post-exposure malaria prophylaxis. Within 12 months, 6 of the 214 volunteers receiving primaquine and 7 of 378 receiving tafenoquine had developed vivax malaria. Overall, volunteers preferred the shorter course of tafenoquine.

Identificador

http://espace.library.uq.edu.au/view/UQ:63914

Idioma(s)

eng

Publicador

Royal Society of Tropical Medicine and Hygiene

Palavras-Chave #Public, Environmental & Occupational Health #Tropical Medicine #Malaria #Plasmodium Vivax #Chemotherapy #Tafenoquine #Primaquine #Bougainville Island #Nonimmune Travelers #Wr-238605 #Antimalarial #Doxycycline #C1 #321202 Epidemiology #730101 Infectious diseases
Tipo

Journal Article